⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL288786 | 1.00 | — | — | |
| SCHEMBL288677 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL17223559 | 0.98 | FDPS (0.43) | — | |
| Hydrochloric Acid SCHEMBL2035544 | 0.98 | FDPS (0.43) | — | |
| Bromide SCHEMBL9376271 | 0.98 | FDPS (0.43) | — | |
| Hydrochloric Acid SCHEMBL4060601 | 0.98 | FDPS (0.43) | — | |
| Bromide SCHEMBL9376277 | 0.98 | FDPS (0.43) | — | |
| Hydrochloric Acid SCHEMBL643019 | 0.98 | FDPS (0.43) | — | |
| Hydrochloric Acid SCHEMBL22800513 | 0.96 | FDPS (0.42) | — | |
| SCHEMBL644279 | 0.93 | FDPS (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 884 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085092-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2026-03-26 | — | — | US | claimed |
| US-20260015393-A1 | NOVEL NMU RECEPTOR 2 AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2026-01-15 | — | — | US | claimed |
| US-20260001915-A1 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS INC (US) | 2026-01-01 | — | — | US | claimed |
| EP-4028494-B1 | REDUCING FRICTION IN COMBUSTION ENGINES THROUGH FUEL ADDITIVES | CHEVRON ORONITE CO (US) | 2025-08-06 | — | — | EP | claimed |
| CN-120152725-A | Methods of treating obesity using MC4R agonists | 节奏制药公司 | 2025-06-13 | — | — | CN | claimed |
| EP-4554607-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | Rhythm Pharmaceuticals, Inc. (US) | 2025-05-21 | — | — | EP | claimed |
| CN-119075601-A | Organic amine composition, carbon dioxide absorbent and application thereof | 国家能源集团新能源技术研究院有限公司 | 2024-12-06 | — | — | CN | claimed |
| WO-2024015880-A2 | METHODS FOR TREATING OBESITY WITH AN MC4R AGONIST | RHYTHM PHARMACEUTICALS, INC. (US) | 2024-01-18 | — | — | WO | claimed |
| EP-4029513-A1 | MELANOCORTIN-4 RECEPTOR AGONISTS FOR THE TREATMENT OF DISORDERS CHARACTERISED BY POMC GENE HYPERMETHYLATION | Rhythm Pharmaceuticals, Inc. (US) | 2022-07-20 | — | — | EP | claimed |
| CN-113307851-B | Application of active peptide and mesenchymal stem cell exosome for improving skin physiological characteristics in medicines or cosmetics | 珠海医美企业管理有限公司 | 2022-04-29 | — | — | CN | claimed |
| US-20220127305-A1 | MELANOCORTIN RECEPTOR LIGANDS | IPSEN PHARMA SAS (FR) | 2022-04-28 | — | — | US | claimed |
| US-20180118721-A1 | PYRIMIDINE DERIVATIVES | MERCK PATENT GMBH (DE) | 2018-05-03 | — | — | US | claimed |
| EP-3256132-A1 | PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | Merck Patent GmbH (DE) | 2017-12-20 | — | — | EP | claimed |
| CN-107207482-A | Pyrimidine derivatives for treating cancer | 默克专利股份公司 | 2017-09-26 | — | — | CN | claimed |
| CN-106832027-A | The extracting method of gumbo polysaccharide | 浙江海洋大学 | 2017-06-13 | — | — | CN | claimed |
| WO-2016128140-A1 | PYRIMIDINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | MERCK PATENT GMBH (DE) | 2016-08-18 | — | — | WO | claimed |
| CN-101052609-A | Synthesis of 1,5-distributed-2-hydroxy-Gibbatetraen-6-ones | MERCK & CO INC (US) | 2007-10-10 | — | — | CN | claimed |
| JP-4208286-A | — | — | None | — | — | JP | disclosed |
| US-4217238-A | BASIC SALT, SCRUBBING | EXXON RESEARCH & ENGINEERING CO. (US) | 1980-08-12 | — | — | US | disclosed |
| US-4094957-A | CARBON DIOXIDE | EXXON RESEARCH & ENGINEERING CO. (US) | 1978-06-13 | — | — | US | disclosed |